James D. Evans

Co-Chair, Capital Markets & Public Companies

Partner, Corporate  

Seattle | Mountain View 206.389.4559 (SEA) 650.335.7941 (MV)


James Evans is the co-chair of the Capital Markets & Public Companies​ group and focuses his practice on corporate and securities law, representing technology and life sciences companies of international prominence in a wide range of corporate matters. He has extensive experience in capital markets transactions and has represented issuers, underwriters and other parties in a variety of public and private offerings of both equity and debt securities, including some of the most high-profile technology public offerings in history. Jamie has led or co-led offerings that have raised over $40 billion of aggregate proceeds. In addition, Jamie regularly advises on mergers and acquisitions and related securities law issues and provides ongoing advice to both public and private companies on general corporate compliance, SEC reporting and governance issues.

Jamie is active in the Seattle and Silicon Valley business communities, regularly speaking on corporate finance topics, including initial public offerings, other corporate finance and capital formation issues and SEC regulation. He was recognized as a Washington "Super Lawyer" in the area of Securities & Corporate Finance for 2016-2019, and was also named a "Rising Star" in 2012. In 2014, Jamie was named among the top attorneys in the United States under the age of 40 by Law360.

For four consecutive years (2016-2019), Jamie has been highlighted by Legal 500 as among the leading lawyers in U.S. capital markets. The firm as a whole consistently ranks in Tier 1 of Legal 500 's technology transactions and venture capital & emerging companies categories. Fenwick & West is also recognized as a leading law firm for capital markets work.

Jamie began his career at Simpson Thacher & Bartlett LLP where he focused primarily on public offerings and mergers and acquisitions.

Representative initial public offerings have included:

  • Pivotal’s $638.25 million initial public offering
  • Smartsheet’s $175 million initial public offering
  • Redfin's $138 million initial public offering
  • ​ProNAi Therapeutics’ $158.4 million initial public offering
  • Fitbit’s $732 million initial public offering​
  • New Relic’s $115 million initial public offering​
  • LendingClub’s $1 billion initial public offering
  • Facebook’s $16 billion initial public offering
  • King Digital Entertainment’s $499.5 million initial public offering (and its $5.9 billion acquisition by Activision Blizzard)
  • Veeva Systems’ $300 million initial public offering
  • Tableau Software’s $292 million initial public offering
  • Fusion-io’s $268 million initial public offering
  • Green Dot’s $188 million initial public offering
  • Jive Software’s $185 million initial public offering
  • Model N’s $120 million initial public offering
  • Rocket Fuel’s $116 million initial public offering
  • New Relic’s $115 million initial public offering
  • Zillow’s $79 million initial public offering
  • Boingo Wireless’ $77 million initial public offering
  • Trupanion’s $71.3 million initial public offering
  • Underwriters in Adaptive Biotechnologies $345 million initial public offering 

Representative other capital markets transactions have included:

  • Redfin’s $258.3 million public offering
  • Zillow’s $747.5 million follow-on offering
  • Fitbit’s $493 million follow-on offering​
  • Facebook’s $3.8 billion follow-on offering
  • Symantec’s $1.1 billion senior notes offering
  • Tableau Software’s $575 million follow-on offering
  • Zillow’s $473 million follow-on offering
  • Rocket Fuel’s $350 million follow-on offering
  • Fusion-io’s $291 million follow-on offering
  • Green Dot’s $260 million follow-on offering
  • Zillow’s $197 million follow-on offering
  • Extreme Network’s $100 million tender offer
  • ZymoGenetics’ $96.6 million follow-on offering
  • OncoGenex Pharmaceuticals’ $57 million shelf offering
  • Dexcom’s $48 million public offering
​​ ​​​​​​​